Rangaprasad (Ranga) Sarangarajan, PhD, Chief Scientific Officer, Metabolon

Rangaprasad (Ranga) Sarangarajan, Ph.D.

Ranga leads Metabolon’s R&D teams to deliver metabolomics data and insights that expand and accelerate the impact of life sciences research in all its applications, including biopharma and diagnostics.

About Ranga Sarangarajan, Chief Scientific Officer

As CSO and SVP of Clinical and Translational Sciences at BERG, Ranga led multi-functional teams integrating biology, technology, and artificial intelligence analytics to develop a multi-omic, biology-based platform for the discovery of disease-specific and therapeutic targets and diagnostics development. Those efforts established a robust pipeline of assets targeting various diseases and indications, leading several programs through early IND, enabling a First-In-Human Phase 1 and proof-concept Phase 2 clinical program. Ranga obtained his Ph.D. in Pharmaceutical Sciences from the University of Cincinnati and a B.S. in Pharmacy from Maharaja Sayajirao University.

See how Metabolon can advance your path to preclinical and clinical insights